189 related articles for article (PubMed ID: 27520409)
1. Levels of soluble E-selectin in patients with active Behçet's disease.
Sari RA; Kiziltunç A; Tays'y S; Akdem'yr S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 27520409
[TBL] [Abstract][Full Text] [Related]
2. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
3. Selectin adhesion molecules in Behçet's disease.
Haznedaroglu E; Karaaslan Y; Büyükaşik Y; Koşar A; Ozcebe O; Haznedaroglu bC; Kirazli E; Dündar SV
Ann Rheum Dis; 2000 Jan; 59(1):61-3. PubMed ID: 10627429
[TBL] [Abstract][Full Text] [Related]
4. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
5. The significance of immunohistochemistry in the skin pathergy reaction of patients with Behçet's syndrome.
Inaloz HS; Evereklioglu C; Unal B; Kirtak N; Eralp A; Inaloz SS
J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):56-61. PubMed ID: 14678533
[TBL] [Abstract][Full Text] [Related]
6. Serum E-selectin and beta 2-microglobulin levels in Behçet's disease.
Karakuzu A; Aktaş A; Akçay F
J Int Med Res; 2002; 30(1):85-8. PubMed ID: 11921504
[TBL] [Abstract][Full Text] [Related]
7. Serum-soluble selectin levels in patients with Behçet's disease.
Ateş A; Tiryaki OA; Olmez U; Tutkak H
Clin Rheumatol; 2007 Mar; 26(3):411-7. PubMed ID: 17206396
[TBL] [Abstract][Full Text] [Related]
8. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease.
Erdem F; Gündoğdu M; Kiki I; Ali Sari R; Kiziltunç A
Rheumatol Int; 2005 Oct; 25(8):599-603. PubMed ID: 15257411
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides.
Boehme MW; Schmitt WH; Youinou P; Stremmel WR; Gross WL
Am J Med; 1996 Oct; 101(4):387-94. PubMed ID: 8873509
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein-associated phospholipase A2 level in patients with Behçet's disease.
Örem A; Yayli S; Arıca DA; Akcan B; Yücesan FB; Bahadir S
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e289-93. PubMed ID: 22755553
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of soluble P-selectin are increased and associated with disease activity in patients with Behçet's syndrome.
Turkoz Y; Evereklioglu C; Ozkiriş A; Mistik S; Borlu M; Ozerol IH; Duygulu F; Ilhan O
Mediators Inflamm; 2005 Aug; 2005(4):237-41. PubMed ID: 16192675
[TBL] [Abstract][Full Text] [Related]
15. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
[TBL] [Abstract][Full Text] [Related]
16. Soluble adhesion molecules in pediatric rheumatic diseases.
Bloom BJ; Miller LC; Blier PR
J Rheumatol; 2002 Apr; 29(4):832-6. PubMed ID: 11950029
[TBL] [Abstract][Full Text] [Related]
17. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease?
Keskin D; Keskin G; Inal A; Ozışık L
Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of erythrocyte sedimentation rate and C-reactive protein in Behcet's disease activity and manifestations: a cross-sectional study.
Parsaei A; Moradi S; Masoumi M; Davatchi F; Najafi A; Kooshki AM; Hajighadery A; Akhlaghi M; Faezi T; Kavosi H
BMC Rheumatol; 2022 Feb; 6(1):9. PubMed ID: 35144674
[TBL] [Abstract][Full Text] [Related]
19. Role of Serum miR-181b, Proinflammatory Cytokine, and Adhesion Molecules in Behçet's Disease.
El Boghdady NA; Shaker OG
J Interferon Cytokine Res; 2019 Jun; 39(6):347-354. PubMed ID: 30848985
[TBL] [Abstract][Full Text] [Related]
20. Soluble endothelial protein C receptor levels in Behçet patients with and without ocular involvement.
Yalçindağ FN; Batioğlu F; Ozdemir O; Cansizoğlu E; Eğin Y; Akar N
Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1603-8. PubMed ID: 18604550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
